advertisement

Topcon

Stamer WD 19

Showing records 1 to 19 | Display all abstracts from Stamer WD

92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Li G
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Cassidy PS
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Lee C
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Kelly RA; Reina-Torres E
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Read AT; Wang K
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Sherwood JM; Humphries MM
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Ha J; Kuhn M
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Kiang AS; Farrar GJ
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Navarro I
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
O'Brien C
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Cui J; Young K
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Campbell M; Stamer WD
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Gorijavolu R
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Overby DR
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Sulchek T
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Humphries P
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Kopczynski C; Farsiu S
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
O'Callaghan J
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Samples J; Challa P; Ethier CR; Stamer WD
eLife 2021; 10:

Issue 22-1

Change Issue


advertisement

Oculus